81 related articles for article (PubMed ID: 1440491)
1. A rapid monoclonal antibody-based enzyme immunoassay (EIA) for the quantitative determination of soluble fibrin in plasma.
Nieuwenhuizen W; Hoegee-De Nobel E; Laterveer R
Thromb Haemost; 1992 Sep; 68(3):273-7. PubMed ID: 1440491
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody-based quantitative enzyme immunoassay for the determination of plasma fibrinogen concentrations.
Hoegee-de Nobel E; Voskuilen M; Briët E; Brommer EJ; Nieuwenhuizen W
Thromb Haemost; 1988 Dec; 60(3):415-8. PubMed ID: 3070825
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.
Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W
Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813
[TBL] [Abstract][Full Text] [Related]
4. A new enzyme immunoassay for soluble fibrin in plasma, with a high discriminating power for thrombotic disorders.
Bos R; Laterveer-Vreeswijk GH; Lockwood D; Szewczyk K; Nieuwenhuizen W
Thromb Haemost; 1999 Jan; 81(1):54-9. PubMed ID: 9974375
[TBL] [Abstract][Full Text] [Related]
5. Validation, calibration, and specificity of quantitative D-dimer assays.
Dempfle CE
Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
[TBL] [Abstract][Full Text] [Related]
6. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
[TBL] [Abstract][Full Text] [Related]
7. A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo.
Lill H; Spannagl M; Trauner A; Schramm W; Schuller D; Ofenloch-Haehnle B; Draeger B; Naser W; Dessauer A
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):97-102. PubMed ID: 8457660
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a soluble fibrin assay in patients with suspected pulmonary embolism.
Ginsberg JS; Siragusa S; Douketis J; Johnston M; Moffat K; Donovan D; McGinnis J; Brill-Edwards P; Panju A; Patel A; Weitz JI
Thromb Haemost; 1996 Apr; 75(4):551-4. PubMed ID: 8743176
[TBL] [Abstract][Full Text] [Related]
9. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
Dempfle CE
Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
[TBL] [Abstract][Full Text] [Related]
10. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a soluble fibrin assay in patients with suspected deep vein thrombosis.
Ginsberg JS; Siragusa S; Douketis J; Johnston M; Moffat K; Stevens P; Brill-Edwards P; Panju A; Patel A
Thromb Haemost; 1995 Sep; 74(3):833-6. PubMed ID: 8571306
[TBL] [Abstract][Full Text] [Related]
12. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
13. The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer.
Dempfle CE; Zips S; Ergül H; Heene DL;
Thromb Haemost; 2001 Nov; 86(5):1204-9. PubMed ID: 11816708
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immunological and functional assays for measurement of soluble fibrin.
Dempfle CE; Pfitzner SA; Dollman M; Huck K; Stehle G; Heene DL
Thromb Haemost; 1995 Aug; 74(2):673-9. PubMed ID: 8585005
[TBL] [Abstract][Full Text] [Related]
15. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay.
Wiman B; Rånby M
Thromb Haemost; 1986 Apr; 55(2):189-93. PubMed ID: 3087001
[TBL] [Abstract][Full Text] [Related]
16. Soluble fibrin as a molecular marker for a pre-thrombotic state: a mini-review.
Nieuwenhuizen W
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):93-6. PubMed ID: 8457659
[TBL] [Abstract][Full Text] [Related]
17. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
18. A highly sensitive enzyme immunoassay for evaluation of 2'-deoxycytidine plasma level as a prognostic marker for breast cancer chemotherapy.
Darwish IA; Mahmoud AM; Aboul-Fadl T; Al-Majed AR; Khalil NY
Anal Chim Acta; 2009 Jan; 632(2):266-71. PubMed ID: 19110103
[TBL] [Abstract][Full Text] [Related]
19. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
20. Sensitive detection of the activation state of blood coagulation in porcine DIC models by a new fibrin immunoassay.
Spannagl M; Trauner A; Birg A; Frank G; Hoffmann H; Siebeck M; Lill H
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):103-6. PubMed ID: 8457635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
